DLX5 and osteosarcoma: On the contrary, DLX5 overexpression did not induce changes in miR-200 expression, either in SH-SY5Y (Fig. 2d) or in GN11 (neuroendocrine) or in U2OS (osteosarcoma) cells (data not shown).